Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2003
06/04/2003EP0966439B1 Certain cyclic thio substituted acylaminoacid amide derivatives
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0789578B1 Multicatalytic protease inhibitors
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422266A Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422253A Carbamate caspase inhibitors and uses thereof
06/04/2003CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands
06/04/2003CN1422157A Divided dose therapies with vascular damaging activity
06/04/2003CN1421456A Human apolipoprotein polypeptide and its use in resisting vascular proliferation diseases
06/04/2003CN1421237A Externally applied medicated wine for treating cervical spondylosis and its making process
06/04/2003CN1421235A Externally applied medicated wine for treating arthritis and its making process
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/04/2003CN1110327C Novel device for transdermal administration of trimegestone
06/04/2003CN1110316C Black plaster and preparing process thereof
06/04/2003CN1110315C Fracture-setting medicine and its preparing method
06/04/2003CN1110310C Medicated wine for treating atrophic arthritis
06/03/2003US6573390 Muscle relaxant, hypotensive agent, respiratory system disorders, gastrointestinal disorders, fertility, incontinence, shock, antiinflammatory agents, immunology, bone disorders, antiproliferative agents
06/03/2003US6573295 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
06/03/2003US6573293 Anticancer agents
06/03/2003US6573287 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573259 Inhibitors of interleukin-1β converting enzyme
06/03/2003US6573255 Vitamin D analogues
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
06/03/2003US6572874 Vaginal delivery of bisphosphonates
06/03/2003US6572858 Uses for anti-malarial therapeutic agents
06/03/2003CA2273446C Piperidones
05/2003
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
05/30/2003WO2003044009A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003044006A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/30/2003WO2003044000A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043999A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
05/30/2003WO2003043985A1 Heterocyclic compounds and methods of use
05/30/2003WO2003043982A1 Derivatives of andrimide and moiramide b having antibacterial properties
05/30/2003WO2003043673A1 Device having osteoinductive and osteoconductive properties
05/30/2003WO2003043672A1 Preparations appropriate for cartilage tissue formation
05/30/2003WO2003043651A1 Drug mobilizing pluripotent stem cells from tissue into peripheral blood
05/30/2003WO2003043645A1 Compositions comprising organic extracts of geum japonicum thunb var. and the use thereof
05/30/2003WO2003043626A1 Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis
05/30/2003WO2003043625A1 2-aryl-propionic acids and pharmaceutical compositions containing them
05/30/2003WO2003043621A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
05/30/2003WO2003043617A1 Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof
05/30/2003WO2003043613A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
05/30/2003WO2003043583A2 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003WO2003027248A3 Antibody inhibitors of gdf-8 and uses thereof
05/30/2003WO2002100328A3 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002096363A3 Method for treating fibrotic diseases or other indications
05/30/2003WO2002088100A3 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
05/30/2003WO2002016313A3 Integrin receptor inhibitors
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/30/2003CA2467557A1 Agent which mobilizes multipotential stem cells from tissues to peripheral blood
05/30/2003CA2467242A1 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003CA2466733A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2466491A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2466072A1 Substituted indolizine-like compounds and methods of use
05/30/2003CA2464867A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003CA2407302A1 Genes transfection into bony tissues
05/29/2003US20030100772 Oxygen-containing heterocyclic compounds
05/29/2003US20030100608 1,4-disubstituted benzo-fused cycloalkyl urea compounds
05/29/2003US20030100607 Thiolalkyl benzoic acid derivatives
05/29/2003US20030100599 2-amino-fluorene derivatives useful for prophylactic and/or therapeutic treatment of diseases and conditions associated with alpha 4 intergrins or their ligands
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100588 Indole-type inhibitors of p38 kinase
05/29/2003US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid
05/29/2003US20030100572 Such as (4-(6-(2,6-dichlorophenyl)-8-methyl-7-oxo-4a,7,8,8a -tetrahydropyrido(2,3)pyrimidin-2-ylamino)-phenyl)-phosphono -methyl)phosphonic acid for treatment of bone disorders and cancer
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100570 Immunomodulation and effect on cell processes relating to serotonin family receptors
05/29/2003US20030100567 Tyrosine kinase inhibitors
05/29/2003US20030100564 Administering 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione and/or metabolite thereof; treating neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis
05/29/2003US20030100563 Such as 7-((3R)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders
05/29/2003US20030100558 Such as 4-(4-fluorophenyl)-5-(2-phenylmethylamino)pyrimidin-4-yl)-1-ethoxymethyl -(1,2,3)triazole for inhibition of release of inflammatory interleukins; for treatment of osteoarthritis, rheumatoid arthritis, and congestive heart failure
05/29/2003US20030100548 Antiarthritic agents; atherosclerosis and chronic obstructive pulmonary disease treatments
05/29/2003US20030100538 Substituted chalcones as therapeutic compounds
05/29/2003US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer
05/29/2003US20030100503 Neurogenic compositions and methods
05/29/2003US20030100488 Osteoprotegerin binding proteins
05/29/2003US20030100014 Apolipoprotein biopolymer markers predictive of type II diabetes
05/29/2003US20030099732 Proteoglycan Compositions for Treating Prostate and Bladder Inflammatory Conditions
05/29/2003US20030099718 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity
05/29/2003US20030099694 Method for the improvement of transport across adaptable semi-permeable barriers
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099644 CD40 ligand and CD40 agonist compositions and methods of use
05/29/2003US20030099608 Human cytokine receptor
05/28/2003EP1314980A2 A system for cell-based screening
05/28/2003EP1314728A1 Pyridyl and pyrimidinyl imines as intermediates for imidazole derivatives
05/28/2003EP1314721A1 Novel propenohydroxamic acid derivatives
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
05/28/2003EP1314429A2 Use of an antiretroviral compound to manufacture a medicament for the treatment of sjogren's syndrome, systematic lupus erythematosis, scleroderma, or juvenile rheumatoid arthritis
1 ... 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 ... 820